Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 74
Selected: 0
NCT IDTitle
NCT00887406Study of GSK961081 in Healthy Volunteer Subjects
NCT02657122SAD and MAD Study to Evaluate Safety, Tolerability, and Pharmacokinetics (PK) of TD-1473 in Healthy Subjects
NCT05165485Phase 4 COPD and Suboptimal Inspiratory Flow Rate
NCT02663089A Phase 1 (Ph1), Single Dose (SD), GSK961081 Absorption, Distribution, Metabolism, and Excretion (ADME) Study in Healthy Subjects
NCT00391820Evaluate the Safety and Efficacy of a 5-HT4 Agonist in Chronic Constipation (ACCORD Trial)
NCT01333540A Study to Assess the Safety, Tolerability and Clinical Activity of TD-1211 in Patients With Opioid-Induced Constipation
NCT02109172A 7-Day Cross-over Study of QD (Once Daily) and BID (Twice Daily) TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT04587713Single Dose Bioavailability and Ethnobridging PK Study in Healthy Subjects
NCT02903095Single Ascending Dose Study of TD-1439 in Healthy Subjects
NCT01718938Phase 2 Study of Velusetrag in Diabetic or Idiopathic Gastroparesis
NCT03095456Revefenacin Peak Inspiratory Flow Rate (PIFR) Study in COPD
NCT04044339Single and Multiple Ascending Dose, First-in- Human Study in Healthy Subjects
NCT03829657Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT01949103TD-1607 MAD Study in Healthy Subjects
NCT02818686TD-1473 for Active Ulcerative Colitis (UC)
NCT03750552Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure
NCT01458340A Study of TD-9855 in Adults With Attention-Deficit/Hyperactivity Disorder (ADHD)
NCT01321879Study to Evaluate the Safety and Efficacy of Telavancin in the Treatment of Gram Positive Bloodstream Infections in Cancer Patients
NCT03920254TD-1473 Long-Term Safety (LTS) Ulcerative Colitis (UC) Study
NCT01568411A Fixed-Sequence, Two-Period, Open-Label Drug-Drug Interaction Study to Assess the Effect of an Inhibitor of Cytochrome P450 Isoenzyme 3A4 and Permeability Glycoprotein 1 on the Pharmacokinetics of TD-1211
NCT04681079Comparison of Viral Particle Dispersion Following Administration of an MDI or Nebulizer in Subjects With COVID-19
NCT02267525The Diabetic and Idiopathic Gastroparesis Efficacy, Safety, and Tolerability (DIGEST) Study
NCT00674817An Investigation Of The Interaction Of GSK961081 With Inhaled Beta-Agonist And Anti-Muscarinic Drugs.
NCT04589260TD-1058 First-In-Human Study in Healthy Subjects and Subjects With Idiopathic Pulmonary Fibrosis
NCT05696717Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy
NCT01791049TD-1607 SAD Study in Healthy Subjects
NCT017044047 Days of TD-4208 in Subjects With Chronic Obstructive Pulmonary Disease
NCT03652038Single and Multiple Ascending Dose Study of TD-8236 by Inhalation
NCT03758443Efficacy & Safety of TD-1473 in Ulcerative Colitis
NCT02581592Pharmacokinetics of TD-4208 in Patients With Moderate Hepatic Impairment
NCT04315558Revefenacin in Acute Respiratory Insufficiency in COPD
NCT02753855Pharmacokinetics of Telavancin in Normal and Obese Subjects
NCT00550225Succinate Salt Version of GSK961081 for Healthy Volunteers
NCT00442832TD-1792 in Gram-positive Complicated Skin and Skin Structure Infection
NCT07133880Compare the Effects of Nebulizer Versus Inhaler Based Therapy for COPD Using Long-acting Bronchodilators
NCT04688632Thorough QT Study to Evaluate Ampreloxetine in Healthy Subjects
NCT02459080Efficacy Study of Nebulized TD-4208 for Chronic Obstructive Pulmonary Disease (COPD)
NCT02705755TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)
NCT02709928Multiple Ascending Dose Study of TD-0714 in Healthy and Elderly Subjects
NCT03408470TD-1473 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
NCT03555617Food-effect, Drug-Drug Interaction (DDI), and Formulation Bridging Study
NCT02772159TD-4208 Absorption, Distribution, Metabolism and Excretion (ADME) Study in Healthy Male Subjects
NCT02954263Multiple Ascending Dose Study of TD-1439 in Healthy Adult and Elderly Subjects
NCT05091723TD-0903 Pharmacokinetics Study in Healthy Participants With Supplemental Oxygenation
NCT02392208Effect of Dialysis on the Pharmacokinetics of Telavancin in Patients With Chronic Kidney Disease Stage 5
NCT02040792A 28-Day Parallel Group Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD)
NCT00687700A Study to Investigate the Pharmacology of a Dual Pharmacophore in Healthy Volunteers
NCT04200573Effect of Hepatic Impairment on the Pharmacokinetics of a Single Dose of TD-9855
NCT02578082Pharmacokinetics of TD-4208 in Patients With Severe Renal Impairment
NCT01953081A Randomized, Double-Blind Study to Evaluate the Safety, Tolerability, and Pharmacodynamics of a Single Dose of Intravenous TD-8954 Compared With Metoclopramide in Critically Ill Patients With Enteral Feeding Intolerance